Skip to content

Drug May Help Keep Aggressive Prostate Cancer in Check

July 6, 2018

From the Health Day website

Men with localized high-risk prostate cancer can slow its spread by using a cancer drug that’s already on the market, a new clinical trial shows.

The targeted drug enzalutamide (Xtandi) reduced by 71 percent these men’s risk of either dying from their prostate cancer or having the cancer spread to other organs, compared against a placebo. The drug also delayed their prostate cancer’s reappearance by nearly two years, the researchers said.

Learn more

From → Health & Safety

Comments are closed.